Sigma Planning’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-1,900
Closed -$257K – 1364
2021
Q4
$257K Buy
+1,900
New +$224K 0.01% 1158

Other funds holding ABBV

Sigma Planning's ABBV Position: Q3 2026 in Review

Sigma Planning reduced its AbbVie (ABBV) stake by 2.3% in Q3 2026, selling an estimated $328K and leaving 54,707 shares worth $14.3M. The position accounts for 0.37% of the portfolio, ranked #44.

Sigma Planning first reported a position in ABBV in Q4 2014 and has held it in 48 quarters since. The position peaked at $22.7M in Q1 2024. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Sigma Planning held 54,707 shares of AbbVie worth $14.3M as of Q3 2026.
  • Sigma Planning sold 1,279 AbbVie shares in Q3 2026, an estimated $328K.
  • AbbVie made up 0.37% of Sigma Planning's portfolio in Q3 2026, its #44 holding.
  • Sigma Planning first reported a position in AbbVie in Q4 2014 and has held it in 48 quarters since.
  • Sigma Planning's AbbVie position peaked at $22.7M in Q1 2024.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.